Montico M - Search Results

1

IgG antibodies against SARS-CoV-2 decay but persist 4 months after vaccination in a cohort of healthcare workers.

Brisotto G, Muraro E, Montico M, Corso C, Evangelista C, Casarotto M, Caffau C, Vettori R, Cozzi MR, Zanussi S, Turetta M, Ronchese F, Steffan A. Brisotto G, et al. Among authors: montico m. Clin Chim Acta. 2021 Dec;523:476-482. doi: 10.1016/j.cca.2021.10.035. Epub 2021 Oct 29. Clin Chim Acta. 2021. PMID: 34755649 Free PMC article.

2

Emerging Role of Immunomonitoring to Predict the Clinical Outcome of Patients With Malignant Pleural Mesothelioma Treated With Radical Radiation Therapy.

Cangemi M, Montico M, Trovo M, Minatel E, Di Gregorio E, Corona G, Giordari F, Comaro E, Colizzi F, Baboçi L, Steffan A, Revelant A, Muraro E. Cangemi M, et al. Among authors: montico m. Int J Radiat Oncol Biol Phys. 2023 Mar 1;115(3):608-621. doi: 10.1016/j.ijrobp.2022.09.079. Epub 2022 Oct 3. Int J Radiat Oncol Biol Phys. 2023. PMID: 36202181

3

Prognostic Role of Serum Antibody Immunity to p53 Oncogenic Protein in Ovarian Cancer: A Systematic Review and a Meta-Analysis.

Garziera M, Montico M, Bidoli E, Scalone S, Sorio R, Giorda G, Lucia E, Toffoli G. Garziera M, et al. Among authors: montico m. PLoS One. 2015 Oct 9;10(10):e0140351. doi: 10.1371/journal.pone.0140351. eCollection 2015. PLoS One. 2015. PMID: 26451959 Free PMC article. Review.

4

Immunogenetic markers in IL17F predict the risk of metastases spread and overall survival in rectal cancer patients treated with neoadjuvant chemoradiotherapy.

Cecchin E, De Mattia E, Dreussi E, Montico M, Palazzari E, Navarria F, Bergamo F, Belluco C, Quartuccio L, De Vita S, Canzonieri V, Gagno S, Zanusso C, Buonadonna A, Pucciarelli S, De Paoli A, Toffoli G. Cecchin E, et al. Among authors: montico m. Radiother Oncol. 2020 Aug;149:30-37. doi: 10.1016/j.radonc.2020.04.055. Epub 2020 May 5. Radiother Oncol. 2020. PMID: 32387487

5

Risk of intestinal and extra-intestinal cancers in patients with inflammatory bowel diseases: A population-based cohort study in northeastern Italy.

Taborelli M, Sozzi M, Del Zotto S, Toffolutti F, Montico M, Zanier L, Serraino D. Taborelli M, et al. Among authors: montico m. PLoS One. 2020 Jun 23;15(6):e0235142. doi: 10.1371/journal.pone.0235142. eCollection 2020. PLoS One. 2020. PMID: 32574216 Free PMC article.

6

Clinical validity of a DPYD-based pharmacogenetic test to predict severe toxicity to fluoropyrimidines.

Toffoli G, Giodini L, Buonadonna A, Berretta M, De Paoli A, Scalone S, Miolo G, Mini E, Nobili S, Lonardi S, Pella N, Lo Re G, Montico M, Roncato R, Dreussi E, Gagno S, Cecchin E. Toffoli G, et al. Among authors: montico m. Int J Cancer. 2015 Dec 15;137(12):2971-80. doi: 10.1002/ijc.29654. Epub 2015 Jul 14. Int J Cancer. 2015. PMID: 26099996

7

New Challenges in Tumor Mutation Heterogeneity in Advanced Ovarian Cancer by a Targeted Next-Generation Sequencing (NGS) Approach.

Garziera M, Roncato R, Montico M, De Mattia E, Gagno S, Poletto E, Scalone S, Canzonieri V, Giorda G, Sorio R, Cecchin E, Toffoli G. Garziera M, et al. Among authors: montico m. Cells. 2019 Jun 14;8(6):584. doi: 10.3390/cells8060584. Cells. 2019. PMID: 31197119 Free PMC article.

8

Association of the HLA-G 3'UTR polymorphisms with colorectal cancer in Italy: a first insight.

Garziera M, Catamo E, Crovella S, Montico M, Cecchin E, Lonardi S, Mini E, Nobili S, Romanato L, Toffoli G. Garziera M, et al. Among authors: montico m. Int J Immunogenet. 2016 Feb;43(1):32-9. doi: 10.1111/iji.12243. Epub 2015 Dec 21. Int J Immunogenet. 2016. PMID: 26752414

9

Prognostic role of visceral fat for overall survival in metastatic colorectal cancer: A pilot study.

Basile D, Bartoletti M, Polano M, Bortot L, Gerratana L, Di Nardo P, Borghi M, Fanotto V, Pelizzari G, Lisanti C, Garutti M, Buriolla S, Ongaro E, Andreuzzi E, Montico M, Balestreri L, Miolo G, Toffoli G, Aprile G, Puglisi F, Buonadonna A. Basile D, et al. Among authors: montico m. Clin Nutr. 2021 Jan;40(1):286-294. doi: 10.1016/j.clnu.2020.05.019. Epub 2020 May 23. Clin Nutr. 2021. PMID: 32546390

10

Impact of DNA repair gene polymorphisms on the risk of biochemical recurrence after radiotherapy and overall survival in prostate cancer.

Zanusso C, Bortolus R, Dreussi E, Polesel J, Montico M, Cecchin E, Gagno S, Rizzolio F, Arcicasa M, Novara G, Toffoli G. Zanusso C, et al. Among authors: montico m. Oncotarget. 2017 Apr 4;8(14):22863-22875. doi: 10.18632/oncotarget.15282. Oncotarget. 2017. PMID: 28206966 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

113 results

Search Page

Filters